Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dunne

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Stem Cells (Dayton, Ohio)|July 25, 2024
Unveiling impaired vascular function and cellular heterogeneity in diabetic donor-derived vascular organoidsHojjat Naderi-Meshkin, Wiwit A Wahyu Setyaningsih, Andrew Yacoub, et al.
Disease Models & Mechanisms|February 3, 2022
Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional dataBaharak Ahmaderaghi, Raheleh Amirkhah, James Jackson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survivalMatthew Alderdice, Philip D Dunne, Aidan J Cole, et al.
JCO Precision Oncology|October 17, 2018
Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease ProgressionAlexey Stupnikov, Paul G O'Reilly, Caitriona E McInerney, et al.
The Journal of Biological Chemistry|July 16, 2011
The T cell receptor triggering apparatus is composed of monovalent or monomeric proteinsJohn R James, James McColl, Marta I Oliveira, et al.
Oncotarget|April 25, 2015
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markersChee Wee Ong, Pei Yi Chong, Darragh G McArt, et al.
Molecular Cancer Therapeutics|August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal CancerNyree Crawford, Katie J Stott, Tamas Sessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal CancerPhilip D Dunne, Sonali Dasgupta, Jaine K Blayney, et al.
Molecular Oncology|March 28, 2015
PICan: An integromics framework for dynamic cancer biomarker discoveryDarragh G McArt, Jaine K Blayney, David P Boyle, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Stem Cells (Dayton, Ohio)|July 25, 2024
Unveiling impaired vascular function and cellular heterogeneity in diabetic donor-derived vascular organoidsHojjat Naderi-Meshkin, Wiwit A Wahyu Setyaningsih, Andrew Yacoub, et al.
Disease Models & Mechanisms|February 3, 2022
Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional dataBaharak Ahmaderaghi, Raheleh Amirkhah, James Jackson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survivalMatthew Alderdice, Philip D Dunne, Aidan J Cole, et al.
JCO Precision Oncology|October 17, 2018
Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease ProgressionAlexey Stupnikov, Paul G O'Reilly, Caitriona E McInerney, et al.
The Journal of Biological Chemistry|July 16, 2011
The T cell receptor triggering apparatus is composed of monovalent or monomeric proteinsJohn R James, James McColl, Marta I Oliveira, et al.
Oncotarget|April 25, 2015
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markersChee Wee Ong, Pei Yi Chong, Darragh G McArt, et al.
Molecular Cancer Therapeutics|August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal CancerNyree Crawford, Katie J Stott, Tamas Sessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal CancerPhilip D Dunne, Sonali Dasgupta, Jaine K Blayney, et al.
Molecular Oncology|March 28, 2015
PICan: An integromics framework for dynamic cancer biomarker discoveryDarragh G McArt, Jaine K Blayney, David P Boyle, et al.
Pageof 14